Free Trial
→ Trump’s national nightmare is here (From Porter & Company) (Ad) Free REGN Stock Alerts

Regeneron Pharmaceuticals (REGN) Short Interest Ratio & Short Volume

Regeneron Pharmaceuticals logo
$558.87 +13.41 (+2.46%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$564.00 +5.13 (+0.92%)
As of 08/1/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Regeneron Pharmaceuticals Short Interest Data

Regeneron Pharmaceuticals (REGN) has a short interest of 2.07 million shares, representing 1.99% of the float (the number of shares available for trading by the public). This marks a -8.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 858,977 shares to cover all short positions.

Current Short Interest
2,070,000 shares
Previous Short Interest
2,250,000 shares
Change Vs. Previous Month
-8.00%
Dollar Volume Sold Short
$1.13 billion
Short Interest Ratio
1.6 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
107,965,000 shares
Float Size
104,070,000 shares
Short Percent of Float
1.99%
Today's Trading Volume
1,656,418 shares
Average Trading Volume
858,977 shares
Today's Volume Vs. Average
193%
Short Selling Regeneron Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

REGN Short Interest Over Time

REGN Days to Cover Over Time

REGN Percentage of Float Shorted Over Time

Regeneron Pharmaceuticals Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20252,070,000 shares $1.13 billion -8.0%2.0%1.6 $547.96
6/30/20252,250,000 shares $1.18 billion +10.8%2.2%1.7 $525.00
6/15/20252,030,000 shares $1.07 billion -24.8%2.0%1.5 $529.24
5/31/20252,700,000 shares $1.33 billion -3.6%2.6%2 $493.24
5/15/20252,800,000 shares $1.64 billion -3.1%2.7%2.5 $584.99
4/30/20252,890,000 shares $1.73 billion +11.2%2.8%2.7 $598.76
4/15/20252,600,000 shares $1.45 billion -6.8%2.6%2.6 $557.91
3/31/20252,790,000 shares $1.77 billion -14.2%2.8%2.8 $634.23
3/15/20253,250,000 shares $2.17 billion +26.5%3.2%3.5 $666.87
2/28/20252,570,000 shares $1.80 billion +16.8%2.5%2.8 $698.74
2/15/20252,200,000 shares $1.48 billion +0.5%2.2%2.5 $673.60
1/31/20252,190,000 shares $1.47 billion +3.3%N/A2.4 $672.98
1/15/20252,120,000 shares $1.49 billion +1.0%N/A2.4 $703.43
12/31/20242,100,000 shares $1.50 billion +11.7%N/A2.6 $712.33
12/15/20241,880,000 shares $1.37 billion +4.4%N/A2.2 $731.30
11/30/20241,800,000 shares $1.35 billion +0.6%N/A2.3 $750.22
11/15/20241,790,000 shares $1.35 billion -3.2%N/A2.5 $756.81
10/31/20241,850,000 shares $1.55 billion +7.6%N/A2.9 $838.20
10/15/20241,720,000 shares $1.75 billion -0.6%N/A3 $1,016.53
9/30/20241,730,000 shares $1.82 billion -12.6%N/A3.3 $1,051.24
9/15/20241,980,000 shares $2.28 billion -5.7%N/A4.1 $1,153.35
8/31/20242,100,000 shares $2.49 billion -0.5%N/A4.6 $1,184.69
8/15/20242,110,000 shares $2.48 billion +5.0%N/A4.7 $1,175.33
7/31/20242,010,000 shares $2.17 billion +6.4%N/A4.6 $1,079.19
7/15/20241,890,000 shares $2.05 billion -7.4%N/A4.3 $1,082.11
6/30/20242,040,000 shares $2.14 billion +10.3%N/A4.5 $1,051.03
6/15/20241,850,000 shares $1.92 billion +5.7%N/A4.1 $1,036.52
5/31/20241,750,000 shares $1.72 billion +7.4%N/A4 $980.16
5/15/20241,630,000 shares $1.59 billion +3.8%N/A3.7 $978.21
4/30/20241,570,000 shares $1.40 billion +13.0%N/A3.4 $890.66
4/15/20241,390,000 shares $1.25 billion -2.1%N/A3 $898.56
3/31/20241,420,000 shares $1.37 billion +2.2%N/A3 $962.49
3/15/20241,390,000 shares $1.34 billion +2.2%N/A2.7 $964.47
2/29/20241,360,000 shares $1.31 billion -0.7%N/A2.4 $966.09
2/15/20241,370,000 shares $1.31 billion +9.6%N/A2.4 $954.73
1/31/20241,250,000 shares $1.18 billion +16.8%N/A2.2 $942.78
1/15/20241,070,000 shares $998.52 million +0.9%1.0%1.9 $933.20
12/31/20231,060,000 shares $930.99 million -13.1%1.0%2 $878.29
12/15/20231,220,000 shares $1.05 billion -0.8%1.2%2.4 $859.14
11/30/20231,230,000 shares $1.01 billion -12.1%1.2%2.7 $823.81
Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift (Ad)

Trump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to unlock federal lands, oil reserves, and buried minerals... all for profit. Trump's team is already executing the orders... and Wall Street legend Whitney Tilson is stepping forward to show you how to position before the deadline.

Click here to see the full story.
11/15/20231,400,000 shares $1.11 billion +6.9%1.3%3.3 $792.38
10/31/20231,310,000 shares $1.02 billion -4.4%1.3%3 $779.89
10/15/20231,370,000 shares $1.15 billion +16.1%1.3%3 $839.63
9/30/20231,180,000 shares $971.09 million -18.6%1.1%2.4 $822.96
9/15/20231,450,000 shares $1.19 billion -2.0%1.4%2.5 $823.40
8/31/20231,480,000 shares $1.22 billion +8.8%1.4%2.5 $826.49
8/15/20231,360,000 shares $1.10 billion +1.5%1.3%2.1 $805.91
7/31/20231,340,000 shares $994.16 million +5.5%1.3%2.1 $741.91
7/15/20231,270,000 shares $912.52 million +17.6%N/A2 $718.52
6/30/20231,080,000 shares $776.02 million -12.2%N/A1.8 $718.54
6/15/20231,230,000 shares $963.18 million +7.9%N/A2.2 $783.07
5/31/20231,140,000 shares $838.54 million -5.8%N/A2 $735.56
5/15/20231,210,000 shares $908.66 million +2.5%N/A2.1 $750.96
4/30/20231,180,000 shares $946.11 million -2.5%1.1%2 $801.79
4/15/20231,210,000 shares $1.00 billion -6.9%1.2%2 $829.33
3/31/20231,300,000 shares $1.07 billion +7.4%1.2%2 $821.67
3/15/20231,210,000 shares $919.96 million +0.8%1.2%1.9 $760.30
2/28/20231,200,000 shares $912.50 million -10.5%1.2%1.9 $760.42
2/15/20231,340,000 shares $1.01 billion -8.2%1.3%2.1 $752.40
1/31/20231,460,000 shares $1.11 billion +3.6%1.4%2.2 $758.47
1/15/20231,410,000 shares $1.02 billion -6.0%1.4%2.2 $722.13
12/30/20221,500,000 shares $1.08 billion +4.2%1.5%2.2 $721.49
12/15/20221,440,000 shares $1.05 billion -7.1%1.4%2.1 $731.27
11/30/20221,550,000 shares $1.17 billion -11.9%1.5%2.1 $751.70
11/15/20221,760,000 shares $1.28 billion -0.6%1.7%2.3 $728.73
10/31/20221,770,000 shares $1.33 billion -16.1%1.7%2.3 $748.75
10/15/20222,110,000 shares $1.55 billion -7.5%2.1%2.8 $736.06
9/30/20222,280,000 shares $1.57 billion -3.8%2.2%3.2 $688.87
9/15/20222,370,000 shares $1.67 billion -18.6%2.3%3.5 $705.85
8/31/20222,910,000 shares $1.69 billion -0.7%2.8%4.3 $581.06
8/15/20222,930,000 shares $1.88 billion -4.6%2.9%4.6 $643.29
7/31/20223,070,000 shares $1.79 billion +7.3%3.0%4.6 $581.69
7/15/20222,860,000 shares $1.74 billion +3.3%2.8%4.3 $607.54
6/30/20222,770,000 shares $1.64 billion +7.4%N/A4.1 $591.13
6/15/20222,580,000 shares $1.45 billion +23.4%N/A3.7 $561.19
5/31/20222,090,000 shares $1.39 billion -4.1%N/A3.1 $664.74
5/15/20222,180,000 shares $1.41 billion +0.9%N/A3.4 $645.52
4/30/20222,160,000 shares $1.42 billion +0.5%N/A3.2 $659.11
4/15/20222,150,000 shares $1.58 billion -2.3%2.1%3 $733.02
3/31/20222,200,000 shares $1.54 billion -8.0%2.1%3 $698.42
3/15/20222,390,000 shares $1.59 billion +6.7%2.3%3.3 $665.93
2/28/20222,240,000 shares $1.39 billion +4.7%2.2%3 $618.36
2/15/20222,140,000 shares $1.35 billion +19.6%2.1%2.8 $630.15
1/31/20221,790,000 shares $1.09 billion -1.7%1.7%2.4 $608.59
1/15/20221,820,000 shares $1.12 billion +11.0%1.8%2.4 $615.24
12/31/20211,640,000 shares $1.04 billion +7.2%1.6%2.2 $631.52
12/15/20211,530,000 shares $1.01 billion +3.4%1.5%1.9 $657.93
11/30/20211,480,000 shares $942.06 million -8.1%1.4%2 $636.53
11/15/20211,610,000 shares $1.04 billion -14.4%1.6%2.1 $647.73
10/29/20211,880,000 shares $1.20 billion +6.8%1.8%2.3 $639.94
Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift (Ad)

Trump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to unlock federal lands, oil reserves, and buried minerals... all for profit. Trump's team is already executing the orders... and Wall Street legend Whitney Tilson is stepping forward to show you how to position before the deadline.

Click here to see the full story.
10/15/20211,760,000 shares $973.70 million -2.2%1.7%2.2 $553.24
9/30/20211,800,000 shares $1.09 billion +14.7%1.8%2.4 $605.18
9/15/20211,570,000 shares $1.02 billion +15.4%1.5%2 $652.00
8/31/20211,360,000 shares $915.82 million -3.6%1.3%1.7 $673.40
8/13/20211,410,000 shares $880.95 million -11.3%1.4%1.8 $624.79
7/30/20211,590,000 shares $913.63 million -13.6%1.6%2.1 $574.61
7/15/20211,840,000 shares $1.08 billion +30.5%1.8%2.4 $589.32
6/30/20211,410,000 shares $787.54 million -26.6%1.4%1.8 $558.54
6/15/20211,920,000 shares $1.01 billion -9.0%1.9%2.4 $527.49
5/28/20212,110,000 shares $1.06 billion -5.4%2.1%2.6 $502.43
5/14/20212,230,000 shares $1.15 billion -4.7%2.2%2.6 $517.17
4/30/20212,340,000 shares $1.13 billion -14.9%2.3%2.5 $485.00
4/15/20212,750,000 shares $1.32 billion +24.4%2.7%2.8 $481.16
3/31/20212,210,000 shares $1.04 billion -16.9%2.2%2.1 $470.67
3/15/20212,660,000 shares $1.25 billion +14.7%2.6%2.6 $471.46
2/26/20212,320,000 shares $1.05 billion +10.0%2.3%2.2 $453.19
2/12/20212,110,000 shares $1.04 billion +8.8%2.1%2 $490.54
1/29/20211,940,000 shares $982.16 million -18.8%1.9%2 $506.27
1/15/20212,390,000 shares $1.24 billion +6.2%2.4%2.6 $517.91
12/31/20202,250,000 shares $1.08 billion +14.8%2.2%2.4 $478.30
12/15/20201,960,000 shares $980.74 million -8.0%1.9%1.9 $500.38
11/30/20202,130,000 shares $1.09 billion +6.0%2.1%2.2 $514.05
11/15/20202,010,000 shares $1.14 billion -7.4%2.0%2.1 $566.43
10/30/20202,170,000 shares $1.21 billion -6.9%2.1%2.4 $555.79
10/15/20202,330,000 shares $1.40 billion +13.7%2.3%2.7 $600.82
9/30/20202,050,000 shares $1.15 billion +28.1%2.0%2.4 $559.78
9/15/20201,600,000 shares $927.84 million +0.6%1.6%2.1 $579.90
8/31/20201,590,000 shares $985.69 million -0.6%1.6%2 $619.93
8/14/20201,600,000 shares $980.11 million -15.3%1.6%1.4 $612.57

REGN Short Interest - Frequently Asked Questions

What is Regeneron Pharmaceuticals' current short interest?

Short interest is the volume of Regeneron Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 2,070,000 shares of REGN short. 1.99% of Regeneron Pharmaceuticals' shares are currently sold short. Learn More on Regeneron Pharmaceuticals' current short interest.

What is a good short interest ratio for Regeneron Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. REGN shares currently have a short interest ratio of 2.0. Learn More on Regeneron Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Regeneron Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Regeneron Pharmaceuticals: Allianz Asset Management GmbH, Twin Tree Management LP, IMC Chicago LLC, Union Bancaire Privee UBP SA, Covenant Asset Management LLC, Baader Bank Aktiengesellschaft, Quaker Wealth Management LLC, Jane Street Group LLC, Goldman Sachs Group Inc., Parallax Volatility Advisers L.P., Millennium Management LLC, Cubist Systematic Strategies LLC, Nomura Holdings Inc., Twin Tree Management LP, BNP Paribas Financial Markets, Eisler Capital Management Ltd., Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Persistent Asset Partners Ltd, Arrowpoint Investment Partners Singapore Pte. Ltd., JPMorgan Chase & Co., Citigroup Inc., Readystate Asset Management LP, Allianz Asset Management GmbH, and Covenant Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Regeneron Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.99% of Regeneron Pharmaceuticals' floating shares are currently sold short.

Is Regeneron Pharmaceuticals' short interest increasing or decreasing?

Regeneron Pharmaceuticals saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 2,070,000 shares, a decline of 8.0% from the previous total of 2,250,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Regeneron Pharmaceuticals' float size?

Regeneron Pharmaceuticals currently has issued a total of 107,960,000 shares. Some of Regeneron Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Regeneron Pharmaceuticals currently has a public float of 104,070,000 shares.

How does Regeneron Pharmaceuticals' short interest compare to its competitors?

1.99% of Regeneron Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Regeneron Pharmaceuticals: Amgen Inc. (2.74%), Gilead Sciences, Inc. (1.82%), Moderna, Inc. (19.34%), Intellia Therapeutics, Inc. (27.87%), Vir Biotechnology, Inc. (12.67%), Vertex Pharmaceuticals Incorporated (1.64%), AbbVie Inc. (0.89%), Eli Lilly and Company (0.90%), Merck & Co., Inc. (1.15%), Pfizer Inc. (1.75%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short Regeneron Pharmaceuticals stock?

Short selling REGN is an investing strategy that aims to generate trading profit from Regeneron Pharmaceuticals as its price is falling. REGN shares are trading up $13.41 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Regeneron Pharmaceuticals?

A short squeeze for Regeneron Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REGN, which in turn drives the price of the stock up even further.

How often is Regeneron Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REGN, twice per month. The most recent reporting period available is July, 15 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:REGN) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsored
Buffett to put 90% of his money in this one stock?
CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...
Altimetry | Sponsored
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsored
Digital Dollar Alert: Protect Your Wealth Before It’s Too Late
134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...
American Alternative | Sponsored
China just unlocked Nvidia’s AI chips—what that means for you
Tired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...
Timothy Sykes | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored
Why AMZN, GOOG, MSFT might destroy NVDA
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...
InvestorPlace | Sponsored
Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
Crypto 101 Media | Sponsored